When is the next results date for Aashka Hospitals?

No Upcoming Board Meetings

Has Aashka Hospitals declared dividend?

No Dividend History Available

Who are the peers of the Aashka Hospitals?

Aashka Hospitals' peers include Max Healthcare, Apollo Hospitals, Fortis Health, Narayana Hrudaya, Global Health, Lotus Eye Hospital, Nephro Care, Maitreya, and KHFM Hospitality. Aashka Hospitals has below average management risk, growth, and capital structure compared to its peers, with a 1-year return of 25.00%.

Peers: The peers of Aashka Hospitals are Max Healthcare, Apollo Hospitals, Fortis Health., Narayana Hrudaya, Global Health, Lotus Eye Hospit, Nephro Care, Maitreya, KHFM Hospitality.<BR><BR>Quality Snapshot: Excellent management risk is observed at Max Healthcare, Apollo Hospitals, Narayana Hrudaya, Nephro Care, and Global Health, while Good management risk is found at Fortis Health. Average management risk is seen at Lotus Eye Hospit and Maitreya, and the rest. Below Average management risk is present at Aashka Hospitals and KHFM Hospitality. In terms of Growth, Excellent growth is noted at Max Healthcare and Nephro Care, Good growth is found at Fortis Health and Narayana Hrudaya, while Average growth is observed at Global Health, and the rest. Aashka Hospitals shows Below Average growth. For Capital Structure, Excellent capital structure is seen at Max Healthcare and Global Health, Good capital structure is found at Fortis Health, Narayana Hrudaya, Lotus Eye Hospit, and Nephro Care, while Average capital structure is noted at Apollo Hospitals and Maitreya, and the rest. Aashka Hospitals and KHFM Hospitality have Below Average capital structure.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Fortis Health. at 59.65%, while the peer with the lowest is Nephro Care at 0.00%. Aashka Hospitals has a 1-year return of 25.00%, which is lower than Fortis Health. but higher than Nephro Care. Additionally, Global Health, Aashka Hospitals, Lotus Eye Hospit, and KHFM Hospitality have negative six-month returns.

Is Aashka Hospitals overvalued or undervalued?

As of May 27, 2025, Aashka Hospitals is considered overvalued with a PE ratio of 91.61 and an EV to EBITDA of 57.47, significantly higher than its peers, despite a low ROE of 2.58% and recent underperformance compared to the market.

As of 27 May 2025, Aashka Hospitals has moved from a grade of "does not qualify" to "very expensive." The company is currently overvalued, with a PE ratio of 91.61, an EV to EBITDA of 57.47, and a ROE of 2.58%. In comparison, peers such as Apollo Hospitals Enterprise Ltd. have a significantly lower PE ratio of 69.03 and an EV to EBITDA of 34.71, while Fortis Healthcare Ltd. stands at a PE of 68.71 and an EV to EBITDA of 37.55, indicating that Aashka is trading at a premium relative to its competitors.<BR><BR>The high valuation metrics suggest that Aashka Hospitals is not justified by its financial performance, especially considering its low ROCE of 1.16%. Additionally, while the stock has shown strong performance over the past year with a return of 21.56% compared to the Sensex's 7.55%, the year-to-date performance of -11.11% against the Sensex's 5.56% indicates a potential correction ahead. Overall, the current valuation does not align with the company's financial fundamentals, reinforcing the conclusion that Aashka Hospitals is overvalued.

What is the technical trend for Aashka Hospitals?

As of April 30, 2025, Aashka Hospitals exhibits a mildly bearish trend, driven by bearish MACD and moving averages, despite some mixed signals from Bollinger Bands and KST.

As of 30 April 2025, the technical trend for Aashka Hospitals has changed from sideways to mildly bearish. The weekly MACD is bearish, while the monthly MACD is mildly bearish, indicating a negative momentum shift. The daily moving averages also reflect a bearish stance. Although the weekly Bollinger Bands are bearish, the monthly Bollinger Bands show a mildly bullish outlook, suggesting some potential for recovery. The KST indicates a mildly bullish trend on the weekly and bullish on the monthly, which contrasts with the overall bearish sentiment. The Dow Theory shows no trend on the weekly and mildly bearish on the monthly, further supporting the bearish outlook. Overall, the current stance is mildly bearish, driven primarily by the bearish indicators in MACD and moving averages, despite some mixed signals from KST and Bollinger Bands.

Who are in the management team of Aashka Hospitals?

As of March 2021, the management team of Aashka Hospitals includes Bipinchandra Shah (Chairman & Managing Director), Dr. Parag Thaker, Shreyarthi Shah, Hiteshkumar Shah (Independent Director), Umang Shah (Additional Director), and Mayank Agarwal (Company Secretary & Compliance Officer). Each member plays a key role in the company's governance and operations.

As of March 2021, the management team of Aashka Hospitals includes the following individuals:<BR><BR>1. Bipinchandra Shah - Chairman & Managing Director<BR>2. Dr. Parag Thaker - Director<BR>3. Shreyarthi Shah - Director<BR>4. Hiteshkumar Shah - Independent Director<BR>5. Umang Shah - Additional Director<BR>6. Mayank Agarwal - Company Secretary & Compliance Officer<BR><BR>Each member of the management team holds a significant role within the company, contributing to its governance and operational oversight.

What does Aashka Hospitals do?

Aashka Hospitals Ltd is a micro-cap company in the hospital industry, incorporated in 2012, with no recent revenue or profit data available. Key metrics include a market cap of INR 229 Cr, a P/E ratio of 92.00, and a debt-equity ratio of 0.19.

Overview: <BR>Aashka Hospitals Ltd operates in the hospital industry and is categorized as a micro-cap company.<BR><BR>History: <BR>Aashka Hospitals Limited was originally incorporated as a Private Limited Company under the name "Aashka Hospitals Private Limited" on November 09, 2012. There are no reported status changes, and revenue and profit data are not available for the latest quarter.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: N/A <BR>Most recent Net Profit: N/A <BR>Market-cap value: INR 229 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 92.00 <BR>Industry P/E: 59 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.19 <BR>Return on Equity: 2.58% <BR>Price-to-Book: 2.38<BR><BR>Contact Details: <BR>Registrar Address: Not available. <BR>Phone: N/A <BR>Email: N/A <BR>Website: N/A

Who are the top shareholders of the Aashka Hospitals?

The top shareholder of Aashka Hospitals is Bipinchandra Dineshbhai Shah, holding 49.63%, with no pledged promoter holdings. The highest public shareholder is Mohit Prakash Jalan at 2.38%, while individual investors own 30.16% of the shares.

The top shareholders of Aashka Hospitals are primarily the promoters, with Bipinchandra Dineshbhai Shah holding the largest share at 49.63%. There are no pledged promoter holdings, and the company does not have any mutual fund or foreign institutional investor (FII) holdings. The highest public shareholder is Mohit Prakash Jalan, who holds 2.38%. Additionally, individual investors collectively hold 30.16% of the company's shares.

How big is Aashka Hospitals?

As of 24th July, Aashka Hospitals Ltd has a market capitalization of 208.00 Cr, classifying it as a Micro Cap company. Recent financial data, including Net Sales and Net Profit, is unavailable, but as of March 2024, Shareholder's Funds are valued at 96.27 Cr and Total Assets at 121.45 Cr.

As of 24th July, Aashka Hospitals Ltd has a market capitalization of 208.00 Cr, which classifies it as a Micro Cap company.<BR><BR>There is no valid financial data available for the latest quarterly performance, including Net Sales and Net Profit for the latest four quarters.<BR><BR>The reporting period for the balance sheet is March 2024. Shareholder's Funds are valued at 96.27 Cr, and Total Assets amount to 121.45 Cr.

How has been the historical performance of Aashka Hospitals?

Aashka Hospitals has experienced fluctuating financial performance, with net sales declining from INR 39.73 crore in March 2022 to INR 22.65 crore in March 2025, while profitability improved, moving from a loss in March 2023 to profits by March 2025. Despite a decrease in total assets, cash flow from operations significantly improved, reaching INR 9 crore in March 2025.

Answer:<BR>The historical performance of Aashka Hospitals shows fluctuations in key financial metrics over the years.<BR><BR>Breakdown:<BR>Aashka Hospitals' net sales have seen a decline from INR 39.73 crore in March 2022 to INR 22.65 crore in March 2025, with a slight decrease from INR 22.87 crore in March 2024. The total operating income followed a similar trend, peaking at INR 39.73 crore in March 2022 and dropping to INR 22.65 crore by March 2025. The total expenditure, excluding depreciation, decreased from INR 31.47 crore in March 2022 to INR 18.37 crore in March 2025. Operating profit (PBDIT) also fluctuated, reaching a high of INR 9.92 crore in March 2021 but falling to INR 4.28 crore in March 2025. Profit before tax improved from a loss of INR 2.57 crore in March 2023 to a profit of INR 3.87 crore in March 2025. Profit after tax followed suit, moving from a loss of INR 2.57 crore in March 2023 to a profit of INR 3.27 crore in March 2025. The company's total assets decreased from INR 129.12 crore in March 2022 to INR 116.05 crore in March 2025, while total liabilities also declined from INR 129.12 crore to INR 116.05 crore during the same period. Cash flow from operating activities improved significantly, reaching INR 9 crore in March 2025, compared to a negative cash flow of INR 62 crore in March 2022. Overall, Aashka Hospitals has shown a recovery in profitability and cash flow in recent years, despite a decline in sales and total assets.

Which are the latest news on Aashka Hospitals?

Why is Aashka Hospitals falling/rising?

As of 03-Dec, Aashka Hospitals Ltd's stock price is stable at Rs 91.25, having shown positive momentum today with a 4.58% gain. However, caution is advised due to erratic trading patterns and a 28.57% decline in delivery volume, indicating potential volatility and reduced investor confidence.

As of 03-Dec, Aashka Hospitals Ltd's stock price is currently stable at Rs 91.25, showing no change from the previous trading session. The stock has recently demonstrated positive momentum, having outperformed its sector by 5.51% today and opened with a gain of 4.58%. This indicates a strong start to the trading day, as the stock reached an intraday high of Rs 91.25.<BR><BR>However, despite these positive indicators, there are factors that suggest caution. The stock has experienced erratic trading, not trading on 2 out of the last 20 days, which may indicate volatility or reduced investor confidence. Additionally, there has been a notable decline in investor participation, with delivery volume falling by 28.57% compared to the 5-day average. This decline in trading activity could signal a lack of sustained interest from investors.<BR><BR>In terms of performance relative to benchmarks, Aashka Hospitals has had a mixed performance over various periods. While it has shown a 4.58% increase over the past week, it has a year-to-date decline of 16.59%, contrasting sharply with the Sensex's gain of 8.92% during the same period. This longer-term underperformance may weigh on investor sentiment.<BR><BR>Overall, while the stock is currently stable and has shown some positive movement today, the combination of erratic trading patterns and declining investor participation suggests that the stock's future performance may be uncertain.